Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1444 |  TNGX Tango Therapeutics, Inc. - Common Stock | 31.59 USD | +4.88% | +3.17% | -1.86% | +444.66% | 4.57 B USD | ||
| 1447 |  NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 36.46 USD | -1.43% | +5.25% | +15.89% | +0.52% | 4.26 B USD | ||
| 1467 |  DNLI Denali Therapeutics Inc. - Common Stock | 26.60 USD | +1.10% | +2.23% | +34.07% | +64.50% | 4.22 B USD | ||
| 1506 |  GPCR Structure Therapeutics Inc - American Depositary Shares | 55.17 USD | -2.58% | +4.29% | +37.93% | +106.32% | 3.92 B USD | ||
| 1517 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.42 USD | -2.73% | -2.73% | +20.97% | +80.98% | 3.87 B USD | ||
| 1529 |  BEAM Beam Therapeutics Inc. - Common Stock | 36.86 USD | -2.80% | +5.50% | +19.71% | +69.39% | 3.79 B USD | ||
| 1543 |  CPRX Catalyst Pharmaceuticals, Inc. - Common Stock | 31.48 USD | -0.03% | +0.13% | +0.58% | +48.42% | 3.85 B USD | ||
| 1552 |  RCUS Arcus Biosciences, Inc. Common Stock | 30.31 USD | +0.07% | -1.56% | +28.49% | +252.03% | 3.81 B USD | ||
| 1555 |  RLAY Relay Therapeutics, Inc. - Common Stock | 20.03 USD | +1.47% | +6.94% | +43.17% | +461.06% | 3.84 B USD | ||
| 1581 |  ALMS Alumis Inc. - Common Stock | 30.96 USD | +5.77% | +10.85% | +60.25% | +586.47% | 3.82 B USD | ||
| 1592 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 39.79 USD | -1.78% | +9.31% | +31.23% | +22.13% | 3.50 B USD | ||
| 1602 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 35.73 USD | -0.39% | +8.67% | +61.38% | -10.61% | 3.52 B USD | ||
| 1611 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 27.68 USD | +0.04% | +5.29% | +26.39% | +97.86% | 3.46 B USD | ||
| 1624 |  DYN Dyne Therapeutics, Inc. - Common Stock | 23.50 USD | -1.38% | +6.77% | +36.95% | +0.38% | 3.36 B USD | ||
| 1634 |  ADPT Adaptive Biotechnologies Corporation - Common Stock | 20.44 USD | -1.83% | -7.26% | +20.73% | +18.42% | 3.27 B USD | ||
| 1678 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 39.67 USD | -0.65% | +7.19% | +36.65% | +45.63% | 3.11 B USD | ||
| 1686 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 50.74 USD | -0.35% | -0.20% | +47.50% | +145.60% | 3.09 B USD | ||
| 1689 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 42.80 USD | -0.37% | +0.35% | +31.94% | +43.91% | 3.07 B USD | ||
| 1697 |  IRON Disc Medicine, Inc. - Common Stock | 78.83 USD | -1.17% | +7.43% | +17.55% | +47.68% | 3.01 B USD | ||
| 1699 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 69.90 USD | -0.92% | +10.43% | +16.00% | +5.81% | 3.01 B USD |
Nouvelles Biotechnology Stocks
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
L’action Incyte atteint un plus haut de 52 semaines à 118,77 $
L’action Prime Medicine bondit après une victoire en arbitrage contre Beam
Nurix Therapeutics : les résultats sous l’œil de l’accord avec Roche
L’action Edgewise Therapeutics atteint un sommet historique à 43,96 $
Stifel abaisse la note de Crinetics à Conserver après l’acquisition par Vertex
Gainers Biotechnology Stocks
 APLMW Apollomics Inc. - Warrant | 0.0184 | +53.33% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 PRME Prime Medicine, Inc. - Common Stock | 4.68 | +17.29% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.17 | +13.21% |
 ANVS Annovis Bio, Inc. Common Stock | 2.16 | +11.92% |
 BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.27 | +11.82% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
 ELOX Eloxx Pharmaceuticals, Inc. | 12.01 | +9.68% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0133 | -20.83% |
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.31 | -16.61% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 PHGE BiomX Inc. COmmon Stock | 0.26 | -13.33% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1053 | -11.21% |
 ICUCW SeaStar Medical Holding Corporation - Warrant | 0.0204 | -10.92% |
 ENLV Enlivex Ltd. - Ordinary Shares | 0.44 | -10.20% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.34 | -9.83% |